Figure 2

CD4 + Decline by Months for Western New York HIV-infected Subjects up to Endpoint (< 500/µL) in HIV-infected Females compared to Males by Survival Functions Model.
CD4 + Decline by Months for Western New York HIV-infected Subjects up to Endpoint (< 500/µL) in HIV-infected Females compared to Males by Survival Functions Model.